Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Hy Laboratories
Rishon LeZion, Israel
B
- Employees
-
Key takeaway
Hy Laboratories Ltd is a leading developer and manufacturer of molecular biology products, including tools for RNA extraction. They are currently developing solutions for RNA/DNA extraction in response to the COVID-19 pandemic, highlighting their expertise in advanced technologies relevant to RNA sequencing.
Reference
Product
Technology of NGS library preparation - HyLabs
Geneyx
Herzliya, Israel
B
11-50 Employees
2018
Key takeaway
Geneyx is dedicated to integrating comprehensive genomic insights into healthcare, emphasizing their advanced Geneyx Analysis platform for RNA sequencing and other genomic data interpretations. Their platform, which is CE-IVD-certified, enhances the analysis process with AI/ML tools and supports various stages of the bioinformatic pipeline, ensuring accuracy and scalability in NGS data analysis.
Reference
Core business
NGS Data Analysis | Clinical Genome Research | Geneyx
Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders Geneyx
Tarom Applied Technologies
Drom HaSharon Regional Council, Israel
B
11-50 Employees
1989
Key takeaway
Pillar Biosciences, a key player in the field of next-generation sequencing (NGS), provides transformative tools that optimize genomics workflows, enabling efficient library preparation and data analysis. This focus on enhancing NGS capabilities directly supports advancements in RNA sequencing and related genomic insights.
Reference
Product
Pillar Biosciences - Tarom Applied technologies
Pillar Biosciences supports next-generation sequencing (NGS) with a technology platform you can depend on. Our transformative NGS tools help you optimize your genomics workflows so you aren’t left waiting on cumbersome library prep and data analysis bottlenecks. Together, we can uncover genomic insights that improve long term outcomes
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Nucleix
Rishon LeZion, Israel
B
11-50 Employees
2008
Key takeaway
Nucleix is a liquid biopsy company that develops innovative non-invasive molecular cancer diagnostic tests, highlighting their capabilities in early disease detection. With a focus on enhancing patient health through advanced liquid biopsy technologies, Nucleix's R&D is actively working on developing assays for various types of cancer.
Reference
Core business
Company - Nucleix
Nucleix Ltd. develops, manufactures and markets innovative non-invasive molecular cancer diagnostic tests. Our highly sensitive and specific tests are based on
AIDGenomics
Rishon LeZion, Israel
B
11-50 Employees
2013
Key takeaway
AID Genomics is focused on developing precision medicine-based diagnostic solutions, particularly in oncology, and is dedicated to providing comprehensive genomic insights through advanced testing platforms. Their current operations include expanding services related to the comprehensive sequencing of tissue and liquid biopsies, which aligns with their mission to improve patient care and enhance treatment recommendations.
Reference
Core business
AID Genomics
AID Genomics is an international group of medical technology companies specialized in the diagnosis and therapy of cancer and infectious diseases like COVID-19. AID Genomics’ advanced testing platforms were developed by a leading team of experts in oncology, molecular biology, molecular pathology, genomics and bioinformatics.
1E Therapeutics
Rishon LeZion, Israel
B
51-100 Employees
2020
Key takeaway
1E Therapeutics is pioneering a new class of programmable oligonucleotide therapeutics that specifically target and silence disease-causing RNAs, highlighting their innovative approach to RNA silencing in drug development.
Reference
Core business
The future of therapeutic RNA silencing
Accellta
Haifa, Israel
B
11-50 Employees
2012
Key takeaway
Accellta specializes in innovative solutions for stem cell culturing, emphasizing their proprietary technology that enables high concentrations of stem cells in dynamic suspension culture. This approach supports the industrialization of both embryonic and induced pluripotent stem cells, which can be crucial for applications in drug discovery and regenerative medicine.
Reference
Product
Technology - Accellta Ltd.
TargetGene Biotechnologies
Rishon LeZion, Israel
B
1-10 Employees
2012
Key takeaway
TargetGene has developed a cutting-edge genome editing platform and possesses valuable intellectual property, positioning them as potential partners in the therapeutics arena, which may relate to advancements in RNA sequencing.
Reference
Product
Technology – TARGETGENE
Tasq.ai
Tel-Aviv, Israel
B
11-50 Employees
2019
Key takeaway
Tasq.ai offers AI transcription solutions that can help create accurate multilingual datasets, which is essential for RNA sequencing analysis. Their unique approach to transcription streamlines data collection processes, making it easier for researchers to obtain high-quality data.
Reference
Product
AI Transcription Solutions | Tasq.ai
Create accurate multilingual datasets for your business. With a unique approach to transcription that allows users to streamline their data collection processes.
Imagene AI
Tel-Aviv, Israel
B
11-50 Employees
2020
Key takeaway
Imagene AI is focused on enhancing cancer patient care through rapid and standardized molecular profiling, which is crucial for effective treatment decisions. Their commitment to real-time biomarker profiling aligns with the advancements in RNA sequencing for oncology.
Reference
Product
Solution - Imagene AI
Biomarkers Profiling in Real-time
Technologies which have been searched by others and may be interesting for you:
Israel's RNA sequencing industry is rapidly evolving, driven by advanced research and a robust biotechnology ecosystem. A key consideration is the regulatory framework, which is influenced by both local and international standards for genomic research. Companies must navigate compliance with data protection laws, especially concerning genetic information. The competitive landscape is intense, with numerous startups and established firms vying for market share, making it essential to evaluate technological innovation and product differentiation among potential partners. Challenges include the high costs associated with RNA sequencing technologies and the need for significant investment in R&D. However, opportunities abound in sectors such as personalized medicine, agriculture, and infectious disease research, particularly given Israel's strengths in these areas. Collaboration between academic institutions and the industry fosters innovation and can accelerate the development of new applications. Environmental concerns also play a role, as sustainable practices in biomanufacturing and waste management are becoming increasingly important. Additionally, the global market relevance of RNA sequencing is expanding, with rising demand for genomic data driving investments and partnerships. Understanding these dynamics is crucial for anyone interested in entering or investing in Israel's RNA sequencing field.
Some interesting numbers and facts about your company results for RNA Sequencing
| Country with most fitting companies | Israel |
| Amount of fitting manufacturers | 68 |
| Amount of suitable service providers | 36 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1989 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for RNA Sequencing
What are related technologies to RNA Sequencing?
Based on our calculations related technologies to RNA Sequencing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on RNA Sequencing?
The most represented industries which are working in RNA Sequencing are IT, Software and Services, Biotechnology, Other, Healthcare, Medical
How does ensun find these RNA Sequencing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.